Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Our final survey of the life-science industry workplace highlights the companies—small and large, domestic and international—that are making their researchers feel valued and at home.
Scientists working in developing countries find that giving back to local communities enriches their own research.
Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.
Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.
Presenting the best life science images and videos of 2012
Much has changed in the 10 years since our first survey of industry researchers. Large companies are now looking to small, nimble ones for services as well as innovation.
After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.
What can a twentysomething naked mole-rat tell us about fighting pain, cancer, and aging?
Targeting the briefest moment in chemistry may lead to an exceptionally strong new class of drugs.
Telomeres have been linked to numerous diseases over the years, but how exactly short telomeres cause diseases and how medicine can prevent telomere erosion are still up for debate.